These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8950631)

  • 1. New directions in therapy for ocular allergy.
    el-Defrawy S; Jackson WB
    Int Ophthalmol Clin; 1996; 36(2):25-44. PubMed ID: 8950631
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal anti-inflammatory and anti-allergic ocular drugs and their use (review of the literature)].
    Inkeniene AM; Klimas R
    Medicina (Kaunas); 2002; 38(8):779-84. PubMed ID: 12474747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular allergy. Mast cells and eosinophils.
    Rothenberg ME; Owen WF; Stevens RL
    Int Ophthalmol Clin; 1988; 28(4):267-74. PubMed ID: 3053485
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular allergy treatments.
    Bielory L
    Clin Rev Allergy Immunol; 2001 Apr; 20(2):201-13. PubMed ID: 11349610
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergy and inflammation: an immunological and therapeutic approach.
    Shukla S; Shukla H; Kumar S; Aharwal RP; Gupta VK; Sandhu SS
    Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):135-50. PubMed ID: 23607779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis in ocular allergic inflammation: recent concepts in the pathogenesis of ocular allergy.
    Solomon A; Puxeddu I; Levi-Schaffer F
    Curr Opin Allergy Clin Immunol; 2003 Oct; 3(5):389-93. PubMed ID: 14501440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007.
    Broide D
    J Allergy Clin Immunol; 2008 Sep; 122(3):475-80. PubMed ID: 18694589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular allergies].
    Messmer EM
    Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies.
    Solomon A; Pe'er J; Levi-Schaffer F
    Curr Opin Allergy Clin Immunol; 2001 Oct; 1(5):477-82. PubMed ID: 11964730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils as a pharmacological target for the treatment of allergic diseases.
    Landolina NA; Levi-Schaffer F
    Curr Opin Pharmacol; 2014 Aug; 17():71-80. PubMed ID: 25128782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of ocular allergy treatment.
    Friedlaender M
    Curr Allergy Asthma Rep; 2001 Jul; 1(4):375-9. PubMed ID: 11892061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An efficacy study of lodoxamide treatment in allergic eye lesions].
    Giuri S; Munteanu GH
    Oftalmologia; 2000; 50(1):68-76. PubMed ID: 11021110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines and anti-cytokines in allergic diseases].
    Fal AM
    Pol Merkur Lekarski; 2003 Jun; 14(84):613-6. PubMed ID: 14524284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy for ocular allergy.
    Jaanus SD
    Optom Clin; 1992; 2(4):35-44. PubMed ID: 1363079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pediatric allergy].
    Baba M
    Arerugi; 2000 Dec; 49(12):1132-4. PubMed ID: 11197877
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ocular allergy: etiopathogenetic and therapeutic aspects].
    Olteanu M; Carstocea B; Pop M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1977; 21(4):241-6. PubMed ID: 204965
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of anti-allergic activity of gossypin and suramin in mast cell-mediated allergy model.
    Ganapaty S; Chandrashekhar VM; Narsu ML
    Indian J Biochem Biophys; 2010 Apr; 47(2):90-5. PubMed ID: 20521621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-allergic activity of R-phycocyanin from Porphyra haitanensis in antigen-sensitized mice and mast cells.
    Liu Q; Wang Y; Cao M; Pan T; Yang Y; Mao H; Sun L; Liu G
    Int Immunopharmacol; 2015 Apr; 25(2):465-73. PubMed ID: 25746371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell and eosinophil surface receptors as targets for anti-allergic therapy.
    Gangwar RS; Landolina N; Arpinati L; Levi-Schaffer F
    Pharmacol Ther; 2017 Feb; 170():37-63. PubMed ID: 27773785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.